My questions. This statement says that Neuromonics is cleard by the FDA. It's approved by the FDA? Is TRT? Also The current treatment landscape primarily consists of therapies that attempt to cover up the symptoms of tinnitus, How is Neuromonics different?
BETHLEHEM, Pa. & DENVER--(BUSINESS WIRE)--Neuromonics today announced the introduction of its Neuromonics Tinnitus Treatment, this week at the AudiologyNOW! 2007 meeting in Denver. The FDA-cleared treatment is proven to interact, interrupt and desensitize disturbances of tinnitus, characterized by ringing in the ears, for long-term benefit. Offered in Australia since 2003, Neuromonics Tinnitus Treatment is now available to patients in the United States who are under the care of either an audiologist or an ear, nose and throat (ENT) specialist.
Tinnitus is a widespread condition affecting up to 50 million sufferers, and considered difficult-to-treat. The Neuromonics Tinnitus Treatment is the most comprehensive therapy that targets the neurological, audiological and psychological basis of tinnitus.
The Neuromonics Tinnitus Treatment, delivered via a non-invasive medical device, consists of a customized neural stimulus, coordinated with customized music. This precisely designed music engages the brain's emotional response center, the limbic system, while the treatment helps enable new neural connections, allowing the brain to filter out the tinnitus sound.
The current treatment landscape primarily consists of therapies that attempt to cover up the symptoms of tinnitus, said Jack Springer, director and CEO of Neuromonics U.S.A. Neuromonics Tinnitus Treatment not only provides immediate relief of a patients symptoms, but also long-term benefits by systematically targeting underlying neurological and psychological causes. By changing the treatment paradigm, our goal is to offer the millions of tinnitus sufferers a lasting, long-term solution to their debilitating symptoms.
At AudiologyNOW! 2007, the Neuromonics Tinnitus Treatment is featured in three presentations. Craig Newman, Ph.D., section head of Audiology and co-director of the Audiology Research Laboratory at the Cleveland Clinic, is giving attendees a practical course on how to effectively incorporate the Neuromonics Treatment into an audiology practice. Paul Davis, Ph.D., at Curtin University of Technology and Neuromonics Chief Scientific Officer, is presenting his latest research showing a significant improvement in tinnitus disturbance for 91 percent of treated patients. This data has been published in the current April 2007 issue of Ear & Hearing, a peer-reviewed journal.
Ear & Hearing Study
The research demonstrates that the Neuromonics Tinnitus Treatment offers clinically significant improvements across a broad range of clinical endpoints, from two to twelve months following treatment. Primary endpoints included tinnitus disturbance and awareness, as well as loudness discomfort levels.
Other key findings include:
The average improvement in tinnitus disturbance was 65% among those receiving treatment.
More than 80% of the study subjects demonstrated clinically significant reduction in their tinnitus awareness.
This study further validates Neuromonics Tinnitus Treatments clinical efficacy, said Dr. Davis. The results prove that the therapy offers both immediate relief and enduring clinical benefits for tinnitus patients seeking to improve their quality of life.
Dr. Davis led the study, which involved 35 patients with moderate-to-severe tinnitus. Participants were instructed to use the Neuromonics Tinnitus Treatment for two to three hours per day, particularly when tinnitus was most disturbing. Treatment was accompanied by regular counseling sessions.
About the Neuromonics Tinnitus Treatment
Clinically administered and monitored, the Neuromonics Tinnitus Treatment is a proven treatment that offers significant long-term reduction of tinnitus disturbance. The therapy is delivered via a compact, lightweight and uniquely designed medical device. Treatment typically occurs over a six-month period, with daily use recommended for two or more hours per day when the tinnitus is most disturbing. The treatment can take place during regular activities such as reading, relaxing or computer work.
The Neuromonics Tinnitus Treatment introduces a modified neural stimulus, embedded and delivered at specific intervals and coordinated with precisely designed music. Customized to the patients unique hearing profile, the treatment enables new neural connections, engages the brains emotional response center (the limbic system), and allows the brain to filter out the tinnitus sound. The Neuromonics Tinnitus Treatment is the most comprehensive, long-term therapy that targets the neurological, audiological and psychological basis of tinnitus.
BETHLEHEM, Pa. & DENVER--(BUSINESS WIRE)--Neuromonics today announced the introduction of its Neuromonics Tinnitus Treatment, this week at the AudiologyNOW! 2007 meeting in Denver. The FDA-cleared treatment is proven to interact, interrupt and desensitize disturbances of tinnitus, characterized by ringing in the ears, for long-term benefit. Offered in Australia since 2003, Neuromonics Tinnitus Treatment is now available to patients in the United States who are under the care of either an audiologist or an ear, nose and throat (ENT) specialist.
Tinnitus is a widespread condition affecting up to 50 million sufferers, and considered difficult-to-treat. The Neuromonics Tinnitus Treatment is the most comprehensive therapy that targets the neurological, audiological and psychological basis of tinnitus.
The Neuromonics Tinnitus Treatment, delivered via a non-invasive medical device, consists of a customized neural stimulus, coordinated with customized music. This precisely designed music engages the brain's emotional response center, the limbic system, while the treatment helps enable new neural connections, allowing the brain to filter out the tinnitus sound.
The current treatment landscape primarily consists of therapies that attempt to cover up the symptoms of tinnitus, said Jack Springer, director and CEO of Neuromonics U.S.A. Neuromonics Tinnitus Treatment not only provides immediate relief of a patients symptoms, but also long-term benefits by systematically targeting underlying neurological and psychological causes. By changing the treatment paradigm, our goal is to offer the millions of tinnitus sufferers a lasting, long-term solution to their debilitating symptoms.
At AudiologyNOW! 2007, the Neuromonics Tinnitus Treatment is featured in three presentations. Craig Newman, Ph.D., section head of Audiology and co-director of the Audiology Research Laboratory at the Cleveland Clinic, is giving attendees a practical course on how to effectively incorporate the Neuromonics Treatment into an audiology practice. Paul Davis, Ph.D., at Curtin University of Technology and Neuromonics Chief Scientific Officer, is presenting his latest research showing a significant improvement in tinnitus disturbance for 91 percent of treated patients. This data has been published in the current April 2007 issue of Ear & Hearing, a peer-reviewed journal.
Ear & Hearing Study
The research demonstrates that the Neuromonics Tinnitus Treatment offers clinically significant improvements across a broad range of clinical endpoints, from two to twelve months following treatment. Primary endpoints included tinnitus disturbance and awareness, as well as loudness discomfort levels.
Other key findings include:
The average improvement in tinnitus disturbance was 65% among those receiving treatment.
More than 80% of the study subjects demonstrated clinically significant reduction in their tinnitus awareness.
This study further validates Neuromonics Tinnitus Treatments clinical efficacy, said Dr. Davis. The results prove that the therapy offers both immediate relief and enduring clinical benefits for tinnitus patients seeking to improve their quality of life.
Dr. Davis led the study, which involved 35 patients with moderate-to-severe tinnitus. Participants were instructed to use the Neuromonics Tinnitus Treatment for two to three hours per day, particularly when tinnitus was most disturbing. Treatment was accompanied by regular counseling sessions.
About the Neuromonics Tinnitus Treatment
Clinically administered and monitored, the Neuromonics Tinnitus Treatment is a proven treatment that offers significant long-term reduction of tinnitus disturbance. The therapy is delivered via a compact, lightweight and uniquely designed medical device. Treatment typically occurs over a six-month period, with daily use recommended for two or more hours per day when the tinnitus is most disturbing. The treatment can take place during regular activities such as reading, relaxing or computer work.
The Neuromonics Tinnitus Treatment introduces a modified neural stimulus, embedded and delivered at specific intervals and coordinated with precisely designed music. Customized to the patients unique hearing profile, the treatment enables new neural connections, engages the brains emotional response center (the limbic system), and allows the brain to filter out the tinnitus sound. The Neuromonics Tinnitus Treatment is the most comprehensive, long-term therapy that targets the neurological, audiological and psychological basis of tinnitus.
